Sonoma pharmaceuticals, inc. announces pricing of $1.7 million public offering of common stock

Boulder, co / accesswire / october 26, 2023 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, today announced the pricing of its public offering of 8,500,000 shares of common stock at a price of $0.20 per share. the gross proceeds of the offering to the company, before deducting placement agent fees and commissions and estimated offering expenses, are expected to be approximately $1.7 million.
SNOA Ratings Summary
SNOA Quant Ranking